DGX Quest Diagnostics

8-K Current Report

Filed: March 12, 2026

Health Care

Services-Medical Laboratories

Quest Diagnostics (DGX) 8-K current report filed with SEC EDGAR on March 12, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

Item 5.02: Departure/Election of Directors or Officers
Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

• Timothy Wentworth, ex-CEO of Walgreens Boots Alliance, elected to DGX Board on March 9, 2026
• Appointed to Compensation & Leadership Development and Quality & Compliance Committees

+2 more insights

Item 7.01 · Regulation FD Disclosure

• Quest Diagnostics elected Mr. Wentworth to its Board of Directors
• Board composition change — new director additions can signal strategic shifts in oversight or targeted expertise

Get deeper insights on Quest Diagnostics

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.